Biosimilars

© GettyImages/Dilok Klaisataporn

Pfizer sells biosimilars plant in China to Wuxi

By Jane Byrne

Pfizer is selling a biologics manufacturing unit in the eastern city of Hangzhou to WuXi Biologics, despite the US pharma giant having ploughed US$350m into the site in 2016 to develop biosimilars.

Follow us

Products

View more

Webinars